Mink Therapeutics Correlations

INKT Stock

USD 0.68 0.01 1.49%

The current 90-days correlation between Mink Therapeutics and Affimed NV is 0.39 (i.e., Weak diversification). The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Mink Therapeutics Correlation With Market

Weak diversification

The correlation between Mink Therapeutics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Moving together with Mink Stock

0.77	VALN	Valneva SE ADR	Pair Corr
0.8	DYAI	Dyadic International	Pair Corr
0.87	ERNA	Eterna Therapeutics	Pair Corr
0.7	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.81	XFOR	X4 Pharmaceuticals	Pair Corr
0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.85	PTN	Palatin Technologies	Pair Corr
0.92	INAB	In8bio Inc	Pair Corr
0.78	MBIO	Mustang Bio	Pair Corr
0.82	MNMD	Mind Medicine	Pair Corr
0.82	MOLN	Molecular Partners	Pair Corr
0.8	NXTC	NextCure	Pair Corr
0.92	ONCT	Oncternal Therapeutics	Pair Corr
0.7	ABCL	Abcellera Biologics	Pair Corr
0.8	ABOS	Acumen Pharmaceuticals	Pair Corr

Moving against Mink Stock

0.86	GILD	Gilead Sciences	Pair Corr
0.82	BMY	Bristol Myers Squibb	Pair Corr
0.72	GNFT	Genfit	Pair Corr
0.6	A	Agilent Technologies Fiscal Year End 18th of November 2024	Pair Corr
0.57	WVE	Wave Life Sciences	Pair Corr
0.57	INBX	Inhibrx Symbol Change	Pair Corr
0.55	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.54	ZURA	Zura Bio Limited	Pair Corr
0.51	LLY	Eli Lilly	Pair Corr
0.85	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.82	TARS	Tarsus Pharmaceuticals	Pair Corr
0.81	BNTX	BioNTech SE	Pair Corr
0.72	SMMT	Summit Therapeutics PLC	Pair Corr
0.68	TCBPW	TC BioPharm plc	Pair Corr
0.64	ANNX	Annexon	Pair Corr
0.63	APGE	Apogee Therapeutics,	Pair Corr
0.61	ABBV	AbbVie Inc	Pair Corr
0.55	TELO	Telomir Pharmaceuticals,	Pair Corr
0.51	ASMB	Assembly Biosciences	Pair Corr

Related Correlations Analysis

	AFMD	IMGN	ADAP	SGMO	DAWN	ABOS	XFOR	INZY	VECT	TERN
AFMD		-0.91	0.84	-0.53	0.39	0.88	0.82	0.27	-0.87	0.0	AFMD
IMGN	-0.91		-0.76	0.61	-0.49	-0.86	-0.73	-0.16	0.89	0.15	IMGN
ADAP	0.84	-0.76		-0.38	0.35	0.74	0.84	0.39	-0.73	0.05	ADAP
SGMO	-0.53	0.61	-0.38		-0.43	-0.43	-0.45	-0.34	0.35	-0.19	SGMO
DAWN	0.39	-0.49	0.35	-0.43		0.52	0.49	0.59	-0.24	0.34	DAWN
ABOS	0.88	-0.86	0.74	-0.43	0.52		0.75	0.33	-0.84	-0.05	ABOS
XFOR	0.82	-0.73	0.84	-0.45	0.49	0.75		0.45	-0.64	0.33	XFOR
INZY	0.27	-0.16	0.39	-0.34	0.59	0.33	0.45		0.07	0.61	INZY
VECT	-0.87	0.89	-0.73	0.35	-0.24	-0.84	-0.64	0.07		0.33	VECT
TERN	0.0	0.15	0.05	-0.19	0.34	-0.05	0.33	0.61	0.33		TERN
	AFMD	IMGN	ADAP	SGMO	DAWN	ABOS	XFOR	INZY	VECT	TERN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VECT	+ 0.89	IMGN
ABOS	+ 0.88	AFMD
ADAP	+ 0.84	AFMD
XFOR	+ 0.84	ADAP
XFOR	+ 0.82	AFMD
XFOR	+ 0.75	ABOS

High negative correlations

IMGN	- 0.91	AFMD
VECT	- 0.87	AFMD
ABOS	- 0.86	IMGN
VECT	- 0.84	ABOS
ADAP	- 0.76	IMGN
VECT	- 0.73	ADAP

Risk-Adjusted Indicators

There is a big difference between Mink Stock performing well and Mink Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mink Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
AFMD	2.22	(0.74)	0.00	(0.39)	0.00	0.00	4.26	(6.82)	13.85
IMGN	5.45	3.42	1.08	(0.64)	1.44	(6.91)	8.32	(4.16)	141.41
ADAP	3.30	(0.64)	0.00	(0.17)	0.00	0.00	6.92	(6.00)	23.16
SGMO	6.94	1.59	0.23	1.03	5.85	(9.82)	24.29	(10.91)	63.91
DAWN	2.19	(0.10)	(0.02)	0.02	2.59	(2.30)	3.84	(3.70)	12.85
ABOS	3.80	(0.22)	0.00	0.02	4.15	(4.73)	9.91	(7.43)	23.13
XFOR	3.51	(0.66)	0.00	(0.19)	0.00	0.00	5.41	(11.11)	25.63
INZY	2.45	(0.10)	0.01	0.05	3.57	(2.58)	6.11	(6.72)	16.25
VECT	2.63	1.35	0.56	(0.40)	0.88	(3.64)	5.61	(3.08)	39.30
TERN	3.60	(0.25)	0.00	(0.08)	0.00	0.00	7.89	(6.46)	34.09

Mink Therapeutics Corporate Management

Kimberly Ha	Head Relations	Profile
Joy Zhou	Vice CMC	Profile
Marcus Dijk	Chief Officer	Profile
Heather Boussios	General Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC